
Lin Yi-chu
politicianFemale0.0Global Dominance: 0.00%
Lin Yi-chu is the deputy head of the Medicinal Product Division of Taiwan's Food and Drug Administration (FDA). She recently spoke at a news conference regarding the FDA's initiative to consider allowing over-the-counter sales of morning-after pills in Taiwan, following a regulatory experiment in Japan.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
FDA specialist Lin Yi-chu said that such drugs are available by prescription only in Taiwan.
More consensus needed for ‘morning-after’ pill sales: FDATaipei Times – major English newspaper in Taiwan, est. 1999·
Taiwan· 2025-10-23
Lin Yi-chu, deputy head of the Medicinal Product Division, discussed the prohibition of fenfluramine in Taiwan.
FDA may approve fenfluramine to treat epilepsyTaipei Times – major English newspaper in Taiwan, est. 1999·
Taiwan· 2025-07-18
Also mentioned
Chung Li Hua

Lin Yi-chu, deputy head of the Medicinal Product Division, discussed the FDA's proposal for over-the-counter sale of morning-after pills.
FDA mulling over-the-counter sale of morning-after pillTaipei Times – major English newspaper in Taiwan, est. 1999·
Taiwan· 2025-04-30
Also mentioned
Tai Yi Yun
